Point72 Middle East FZE’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,500
Closed -$2.92M 1198
2023
Q4
$2.92M Sell
5,500
-6,100
-53% -$2.95M 0.09% 313
2023
Q3
$5.87M Buy
11,600
+5,000
+76% +$2.66M 0.19% 135
2023
Q2
$3.44M Sell
6,600
-10,100
-60% -$5.45M 0.1% 265
2023
Q1
$9.63M Buy
16,700
+10,200
+157% +$5.75M 0.33% 81
2022
Q4
$3.58M Buy
+6,500
New +$3.44M 0.16% 161

Other funds holding TMO

Point72 Middle East FZE's TMO Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 9,475 shares — an estimated $5.03M sold.

Point72 Middle East FZE first reported a position in TMO in Q4 2022 and held it in 5 quarters. The position peaked at $21.2M in Q2 2023. 2,529 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 9,475 Thermo Fisher Scientific shares in Q1 2024, an estimated $5.03M.
  • Point72 Middle East FZE first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 5 quarters.
  • Point72 Middle East FZE's Thermo Fisher Scientific position peaked at $21.2M in Q2 2023.
  • 2,529 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.